Sabra Healthcare SBRA Equity method investments (Note 11)
Equity method investments (Note 11) at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:EquityMethodInvestments.
The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sabra Healthcare's equity method investments (note 11).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sabra Healthcare's equity method investments (note 11)?
- Sabra Healthcare (SBRA) reported equity method investments (note 11) of $116.54M in Q1 2026.
- How has Sabra Healthcare's equity method investments (note 11) changed year-over-year?
- Sabra Healthcare's equity method investments (note 11) decreased by 3.6% year-over-year, from $120.84M to $116.54M.
- What is the long-term trend for Sabra Healthcare's equity method investments (note 11)?
- Over 5 years (2020 to 2025), Sabra Healthcare's equity method investments (note 11) has grown at a -16.4% compound annual growth rate (CAGR), from $288.76M to $118.17M.